3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Ice: new trials by email Literature Review of Ice trials Research Report on Ice
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) MEDI-551 2 mg/kg, Rituximab, ICE - Diffuse Large B-Cell Lymphoma | Phase 2 | Completed | MedImmune LLC | 187 | 2012-02-27 | 2018-03-12 |
| Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL) ofatumumab + ICE, ofatumumab + DHAP - Lymphoma, Large-Cell, Diffuse | Phase 2 | Completed | GlaxoSmithKline | 61 | 2009-05-01 | 2013-03-12 |
| Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study Intra-Cardiac Echocardiography guided Cardioversion, Intracardiac Echo, ICE - Atrial Fibrillation | Phase 1 / Phase 2 | Completed | EP MedSystems | 95 | 2005-03-01 | 2011-05-11 |
Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Non-Hodgkin (2) · Atrial Fibrillation (1) · Lymphoma (1) · Neoplasms (1) · Recurrence (1)
EP MedSystems (1) · GlaxoSmithKline (1) · MedImmune LLC (1)
United States (2) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Netherlands (1) · Poland (1) · Russia (1) · Spain (1) · Turkey (Türkiye) (1)